ArticleLancet (London, England)2021

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.

Georg Mn Behrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.